This study evaluates the feasibility of hyperpolarized 13C MRS for detection of early metabolic response in the myocardium of patients after anthracycline treatment. Patients with breast cancer were studied using hyperpolarized [1-13C]pyruvate before and after doxorubicin. Appearance of [13C]bicarbonate was significantly decreased after doxorubicin compared to the baseline exam while no change in [1-13C]lactate was detected. The reproducibility of hyperpolarized exams was examined by two injections of hyperpolarized [1-13C]pyruvate. The study demonstrates that hyperpolarized 13C spectra of the heart are sensitive to early injury of the mitochondria after doxorubicin therapy in patients with breast cancer in a reproducible manner.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords